Get the app
US › Healthcare

Liquidia Technologies Inc (LQDA)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$44.40-0.20%
Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue
$171.7M
Revenue YoY
+1842.7%
Net profit
$74.7M
EPS
$-0.49
EPS estimate
$0.70
Net margin
43.5%

EPS came in at -0.49 against a street estimate of 0.70 — a miss of 170.0%.

Key statistics

Market cap
$3.78B
P/E
30.4
Forward P/E
10.5
P/B
19.18
Book value
$2.19
EPS (TTM)
$1.39
52-week high
$93.61
52-week low
$22.31
50-day MA
$52.46
200-day MA
$54.31
Beta
0.41

Analyst view

Analysts rate Liquidia Technologies Inc a buy (6 buy, 2 hold, 0 sell out of 8) with an average price target of $54.38.

Shareholding

Insiders
9.21%
Institutions
82.00%

Largest institutional holders

FundStake
BlackRock Inc12.05%
Farallon Capital Management, L.L.C.9.35%
Caligan Partners LP9.07%
Findell Capital Management LLC3.91%
Vanguard Capital Management, LLC3.51%
State Street Corp3.39%
Opaleye Management Inc2.73%
Geode Capital Management, LLC2.37%

Recent filings & reports

DocumentDate
Material agreement · Q4 2026
HEADLINE NUMBERS • Liquidia reached a settlement with United Therapeutics Corporation (UTC) covering all ongoing litigation, including patent, trade-
2026-10-14
Company announcement · Q3 2026
HEADLINE NUMBERS • Liquidia Corporation filed a Form 8-K on September 30, 2026. • The filing concerns litigation involving United Therapeutics Corpo
2026-09-30
Company announcement · Q3 2026
LIQUIDIA CORPORATION – FORM 8-K SUMMARY HEADLINE NUMBERS • Company: Liquidia Corporation (ticker: LQDA, Nasdaq-listed) • Report date: September 3, 2
2026-09-03
Quarterly report · Q2 2026
LIQUIDIA CORPORATION - FORM 10-Q SUMMARY For Quarter Ended June 30, 2026 --- HEADLINE NUMBERS • Cash and cash equivalents: $284.2 million as of Jun
2026-08-12
Results announced · Q3 2026
LIQUIDIA CORPORATION Q2 2026 FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Q2 2026 YUTREPIA net product sales: $170.4 million, up 31% from Q1 2026 ($
2026-08-12
Shareholder vote results · Q2 2026
LIQUIDIA CORPORATION (LQDA) - 8-K SUMMARY HEADLINE NUMBERS • Annual shareholder meeting held June 16, 2026 • 88,893,621 shares outstanding as of Apr
2026-06-17
Company announcement · Q2 2026
LIQUIDIA CORPORATION - FORM 8-K SUMMARY HEADLINE NUMBERS • Company: Liquidia Corporation (NASDAQ: LQDA) • Headquarters: 419 Davis Drive, Suite 100,
2026-06-08
Quarterly report · Q1 2026
LIQUIDIA CORPORATION – Q1 2026 SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Cash and Cash Equivalents: $222.8 million as of March 31, 2026 (up fr
2026-05-11

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Liquidia Technologies Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Data updated 2026-11-07.